Diabetes 54:402-411, 2005
© 2005 by the American Diabetes Association, Inc.
The Extracellular Signal–Regulated Kinase Isoform ERK1 Is Specifically Required for In Vitro and In Vivo Adipogenesis
Frédéric Bost1,
Myriam Aouadi1,
Leslie Caron1,
Patrick Even2,
Nathalie Belmonte3,
Matthieu Prot1,
Christian Dani3,
Paul Hofman4,
Gilles Pagès3,
Jacques Pouysségur3,
Yannick Le Marchand-Brustel1, and
Bernard Binétruy1
1 Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 568, IFR 50, Faculté de Médecine, Université de Nice Sophia Antipolis, Nice, France
2 Unité Mixte de Recherche (UMR) INRA/INA Physiologie de la Nutrition et du Comportement, Paris, France
3 Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 6543, Faculté des Sciences, Université de Nice Sophia Antipolis, Nice, France
4 Institut National de la Santé et de la Recherche Médicale (INSERM) E 0215 and Laboratory of Clinical and Experimental Pathology, Faculté de Médecine and Pasteur Hospital, Université de Nice Sophia Antipolis, Nice, France
Hyperplasia of adipose tissue is critical for the development of obesity, but molecular mechanisms governing normal or pathological recruitment of new adipocytes remain unclear. The extracellular signal–regulated kinase (ERK) pathway plays a pivotal role in many essential cellular functions, such as proliferation and differentiation. Using ERK1–/– mice, we investigated the role of this isoform in adipose tissue development. Mice lacking ERK1 have decreased adiposity and fewer adipocytes than wild-type animals. Furthermore, ERK1–/– mice challenged with high-fat diet are resistant to obesity, are protected from insulin resistance, and have a higher postprandial metabolic rate. To get insights into cellular mechanisms implicated in reduced adiposity in ERK1–/– animals, we analyzed adipocyte differentiation in ERK1–/– cells. Compared with wild-type control cells, mouse embryo fibroblasts and cultures of adult preadipocytes isolated from ERK1–/– adult animals exhibit impaired adipogenesis. An inhibitor of the ERK pathway does not affect the residual adipogenesis of the ERK1–/– cells, suggesting that ERK2 is not implicated in adipocyte differentiation. Our results clearly link ERK1 to the regulation of adipocyte differentiation, adiposity, and high-fat diet–induced obesity. This suggests that a therapeutic approach of obesity targeting specifically the ERK1 isoform and not ERK2 would be of particular interest.
Address correspondence and reprint requests to Frédéric Bost or Bernard Binétruy, INSERM U 568, IFR 50, Faculté de Médecine, Université de Nice- Sophia Antipolis, Avenue de Valombrose, Nice, France. E-mail: bost{at}unice.fr or binetruy{at}unice.fr
Abbreviations:
ERK, extracellular signal–regulated kinase; JNK, c-Jun NH2-terminal kinase; MEK, mitogen-activated protein/ERK kinase; PPAR, peroxisome proliferator–activated receptor; RQ, respiratory quotient

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Ito, T. Suganami, Y. Miyamoto, Y. Yoshimasa, M. Takeya, Y. Kamei, and Y. Ogawa
Role of MAPK Phosphatase-1 in the Induction of Monocyte Chemoattractant Protein-1 during the Course of Adipocyte Hypertrophy
J. Biol. Chem.,
August 31, 2007;
282(35):
25445 - 25452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bifulco, C. Grimaldi, P. Gazzerro, S. Pisanti, and A. Santoro
Rimonabant: Just an Antiobesity Drug? Current Evidence on Its Pleiotropic Effects
Mol. Pharmacol.,
June 1, 2007;
71(6):
1445 - 1456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-A. Kim, J.-H. Kim, Y. Wang, and H. S. Sul
Pref-1 (Preadipocyte Factor 1) Activates the MEK/Extracellular Signal-Regulated Kinase Pathway To Inhibit Adipocyte Differentiation
Mol. Cell. Biol.,
March 15, 2007;
27(6):
2294 - 2308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tresini, A. Lorenzini, C. Torres, and V. J. Cristofalo
Modulation of Replicative Senescence of Diploid Human Cells by Nuclear ERK Signaling
J. Biol. Chem.,
February 9, 2007;
282(6):
4136 - 4151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jager, T. Gremeaux, M. Cormont, Y. Le Marchand-Brustel, and J.-F. Tanti
Interleukin-1{beta}-Induced Insulin Resistance in Adipocytes through Down-Regulation of Insulin Receptor Substrate-1 Expression
Endocrinology,
January 1, 2007;
148(1):
241 - 251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Achard, S. Boullu-Ciocca, R. Desbriere, G. Nguyen, and M. Grino
Renin receptor expression in human adipose tissue
Am J Physiol Regulatory Integrative Comp Physiol,
January 1, 2007;
292(1):
R274 - R282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. S. Newell, H. Su, H. Tornqvist, J. P. Whitehead, J. B. Prins, and L. J. Hutley
Characterization of the transcriptional and functional effects of fibroblast growth factor-1 on human preadipocyte differentiation
FASEB J,
December 1, 2006;
20(14):
2615 - 2617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Dickinson and S. M. Keyse
Diverse physiological functions for dual-specificity MAP kinase phosphatases
J. Cell Sci.,
November 15, 2006;
119(22):
4607 - 4615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang and H. S. Sul
Ectodomain Shedding of Preadipocyte Factor 1 (Pref-1) by Tumor Necrosis Factor Alpha Converting Enzyme (TACE) and Inhibition of Adipocyte Differentiation.
Mol. Cell. Biol.,
July 1, 2006;
26(14):
5421 - 5435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Laviola, S. Perrini, A. Cignarelli, A. Natalicchio, A. Leonardini, F. De Stefano, M. Cuscito, M. De Fazio, V. Memeo, V. Neri, et al.
Insulin signaling in human visceral and subcutaneous adipose tissue in vivo.
Diabetes,
April 1, 2006;
55(4):
952 - 961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bourcier, A. Jacquel, J. Hess, I. Peyrottes, P. Angel, P. Hofman, P. Auberger, J. Pouyssegur, and G. Pages
p44 Mitogen-Activated Protein Kinase (Extracellular Signal-Regulated Kinase 1)-Dependent Signaling Contributes to Epithelial Skin Carcinogenesis.
Cancer Res.,
March 1, 2006;
66(5):
2700 - 2707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Aouadi, K. Laurent, M. Prot, Y. Le Marchand-Brustel, B. Binetruy, and F. Bost
Inhibition of p38MAPK Increases Adipogenesis From Embryonic to Adult Stages
Diabetes,
February 1, 2006;
55(2):
281 - 289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Kortum, D. L. Costanzo, J. Haferbier, S. J. Schreiner, G. L. Razidlo, M.-H. Wu, D. J. Volle, T. Mori, H. Sakaue, N. V. Chaika, et al.
The Molecular Scaffold Kinase Suppressor of Ras 1 (KSR1) Regulates Adipogenesis
Mol. Cell. Biol.,
September 1, 2005;
25(17):
7592 - 7604.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Diabetes Association.
|
|
| |
|